Literature DB >> 24284721

TB vaccine failure was predictable.

Peter Beverley1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24284721     DOI： 10.1038/503469e

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  5 in total

1.  Establishment of an aerosol challenge model of tuberculosis in rhesus macaques and an evaluation of endpoints for vaccine testing.

Authors:  S A Sharpe; H McShane; M J Dennis; R J Basaraba; F Gleeson; G Hall; A McIntyre; K Gooch; S Clark; N E R Beveridge; E Nuth; A White; A Marriott; S Dowall; A V S Hill; A Williams; P D Marsh
Journal:  Clin Vaccine Immunol       Date:  2010-06-09

2.  Vaccines: An age-old problem.

Authors:  Sarah DeWeerdt
Journal:  Nature       Date:  2013-10-10       Impact factor: 49.962

3.  Enhanced immunogenicity and protective efficacy against Mycobacterium tuberculosis of bacille Calmette-Guérin vaccine using mucosal administration and boosting with a recombinant modified vaccinia virus Ankara.

Authors:  Nilu P Goonetilleke; Helen McShane; Carolyn M Hannan; Richard J Anderson; Roger H Brookes; Adrian V S Hill
Journal:  J Immunol       Date:  2003-08-01       Impact factor: 5.422

Review 4.  Immunization strategies against pulmonary tuberculosis: considerations of T cell geography.

Authors:  Carly N Horvath; Zhou Xing
Journal:  Adv Exp Med Biol       Date:  2013       Impact factor: 2.622

5.  MVA.85A boosting of BCG and an attenuated, phoP deficient M. tuberculosis vaccine both show protective efficacy against tuberculosis in rhesus macaques.

Authors:  Frank A W Verreck; Richard A W Vervenne; Ivanela Kondova; Klaas W van Kralingen; Edmond J Remarque; Gerco Braskamp; Nicole M van der Werff; Ariena Kersbergen; Tom H M Ottenhoff; Peter J Heidt; Sarah C Gilbert; Brigitte Gicquel; Adrian V S Hill; Carlos Martin; Helen McShane; Alan W Thomas
Journal:  PLoS One       Date:  2009-04-15       Impact factor: 3.240
  5 in total
  5 in total

Review 1.  TB vaccines; promoting rapid and durable protection in the lung.

Authors:  Peter Andersen; Kevin B Urdahl
Journal:  Curr Opin Immunol       Date:  2015-06-22       Impact factor: 7.486

Review 2.  Novel vaccination strategies against tuberculosis.

Authors:  Peter Andersen; Stefan H E Kaufmann
Journal:  Cold Spring Harb Perspect Med       Date:  2014-06-02       Impact factor: 6.915

3.  MTBVAC vaccine is safe, immunogenic and confers protective efficacy against Mycobacterium tuberculosis in newborn mice.

Authors:  Nacho Aguilo; Santiago Uranga; Dessislava Marinova; Marta Monzon; Juan Badiola; Carlos Martin
Journal:  Tuberculosis (Edinb)       Date:  2015-11-30       Impact factor: 3.131

4.  Immunogenicity and Protective Efficacy of a Fusion Protein Tuberculosis Vaccine Combining Five Esx Family Proteins.

Authors:  Zhi-Hao Xiang; Rui-Feng Sun; Chen Lin; Fu-Zeng Chen; Jun-Tao Mai; Yu-Xiao Liu; Zi-Yan Xu; Lu Zhang; Jun Liu
Journal:  Front Cell Infect Microbiol       Date:  2017-05-31       Impact factor: 5.293

5.  Multi-subunit BCG booster vaccine GamTBvac: Assessment of immunogenicity and protective efficacy in murine and guinea pig TB models.

Authors:  A P Tkachuk; V A Gushchin; V D Potapov; A V Demidenko; V G Lunin; A L Gintsburg
Journal:  PLoS One       Date:  2017-04-28       Impact factor: 3.240
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.